In fact, XPF/ERCC4/FANCQ mutations have mainly been identified in patients with Xeroderma pigmentosum (XP) of complementation group F (XP-F) [5, 7], and later in an individual with the XFE progeroid syndrome [8]. Here, ERCC4 is linked to xeroderma pigmentosum.